Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis Adopts NuGEN's Amplification Tech for Certain GeneChip Analysis

NEW YORK (GenomeWeb News) – Affymetrix service provider Expression Analysis yesterday said it has adopted NuGEN Technologies' Ovation product line for amplifying, fragmenting, and labeling RNA samples for GeneChip array analysis.
 
"We hope to migrate all of our clients who require microarray testing with limited RNA specimens to this service,” Tom Goralski, senior director of laboratory operations at Expression Analysis, said in a statement. “We will continue to evaluate the Ovation system for potential use with whole blood samples."
 
Expression Analysis also said it will begin validating NuGEN’s new WT-Ovation Pico RNA amplification system for ultra-small and/or degraded specimens in early October.
 
"We believe this product may be extremely useful in tumor-based oncology applications," continued Goralski said.
 
Financial terms of the deals were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.